Macular Degeneration

Home » Diseases » Macular Degeneration

CoQ10

In 2001 Ophthalmologica published a study which found that 19 patients with age-related macular degeneration generally had lower CoQ10 levels than 19 aged-matched controls. Based on this data the authors theorize that CoQ10 may have a protective effect against macular degeneration. [Source]
In 2005 Opthalmologica published a double-blind, placebo-controlled trial involving 106 patients which found that CoQ10, along with acetyl-L-carnitine and omega-3 fatty acids were effective in treating early-stage macular degeneration. [Source]
In 2003 Opthalmologica published a study involving 28 patients which found that CoQ10 combined with acetyl-L-carnitine, polyunsaturated fatty acids and vitamin E was effective in improving retinal function in early stage age-related macular degeneration. [Source]
In 2009 Investigative Opthalmology & Visual Science published an in vitro study which found that CoQ10 levels in eye tissue can decline by 40 percent with age, which may be linked to the progression of macular degeneration. [Source]

In 2000 Archives of Ophthalmology published a study involving 644 subjects which found that age-related macular degeneration was associated with hypertension and may have similar underlying causes. [Source]
In 2013 Investigative Ophthalmology & Visual Science published a population-based study based on 963 subjects over the age of 73 which found that high blood pressure was significantly associated with an increased risk for age-related macular degeneration. [Source]
In 2008 the American Journal of Ophthalmology published a study based on retinal photographs from 5,875 participants which found that cardiovascular risk factors, including high blood pressure play a role in advanced age-related macular degeneration. [Source]

In 2006 The Journal of Nutrition published a 12-week, placebo-controlled trial involving 24 females which found that subjects who consumed 6 eggs per week had increased levels of zeaxanthin and macular pigment optical density (MPOD) – a key factor in improving visual performance and reducing the risk of age-related macular degeneration. [Source]